Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

Bayer is pressing ahead with a phase 3 trial ... most apparent in the highest (50 mg) dose group where the risk was reduced by a third. In PACIFIC-AMI, asundexian was unable to reduce the main ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals ...

Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...

Nearly 12 months later, green shoots may finally be appearing following a desperately dark time for the German group that invented aspirin. Bayer announced plans earlier this year to secure €2 ...

Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the ...

Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain ...

For decades, taking low-dose aspirin every day was widely recommended as an easy way to prevent heart attacks and strokes. But that advice has changed.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...